Drug firms could be investigated by the Government's watchdog for 'price gouging' - inflating the cost of vital medication needed by millions of Britons - amid concerns they may profit from the Covid-19 pandemic. But Government officials are also concerned that 'a minority of bad apples' may artificially inflate prices during the pandemic to make money. 'Medicines are subject to supply and demand,' explains Martin Sawer, executive director at the Healthcare Distribution Association, which represents wholesalers. If supply can't meet demand straight away, then the prices go up. But when there are problems and a drug is in short supply, pharmacies may end up paying above the listed price to get hold of it.

Source: Daily Mail June 06, 2020 21:01 UTC